Sorenson John Bradley, EVP of Global Operations at Boston Scientific (BSX), has been a consistent seller of company stock over the past year, with no open-market purchases recorded in his SEC Form 4 filings. Across 42 transactions, his total sell value reached approximately $5.08 million, all in BSX shares, while his acquired value was zero. The most recent activity, concentrated in February 2025, shows eight open-market sales totaling roughly $2.1 million, including a $685,244 sale on February 7, a $671,249 sale on February 12, and smaller dispositions on February 14, 18, and 19. These sales were interspersed with automatic transactions—option exercises (coded M) valued at zero, tax-withholding share surrenders (coded F) totaling over $600,000 in February alone, and compensation grants (coded A) on February 11 and 13—which are mechanical and not discretionary.
The pattern is unambiguous: Bradley has not bought a single share on the open market, and his selling has been steady and substantial. The largest single sale occurred on May 1, 2024, at $1.26 million, followed by a cluster of sales in early January 2025 ($370,792 on January 2 and $210,449 on January 3). The February 2025 sales are notable for their frequency—five open-market sales in eight trading days—suggesting a deliberate liquidation of vested shares, likely tied to a scheduled trading plan. The F-code transactions, which automatically withhold shares to cover tax liabilities on option exercises and grants, are routine and do not reflect discretionary selling, but they do add to the overall reduction in his holdings.
Bradley’s insider activity is entirely one-directional: sell, sell, sell. With no purchases and a cumulative sell value exceeding $5 million, the data indicates a sustained divestment pattern, though the absence of any buy-side conviction makes it impossible to infer a bullish or bearish stance. The recent February 2025 sales, ranging from $127,678 to $685,244, are consistent with his historical behavior, and the mix of M, F, and A codes confirms that much of his equity compensation is being converted to cash rather than retained. For investors tracking insider sentiment, Bradley’s filings show a clear preference for liquidity over accumulation, though the mechanical nature of many transactions tempers any signal.
AI-assisted summary